BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 26379150)

  • 1. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16
    Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM
    Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-tiered score for Ki-67 and p16
    van Zummeren M; Leeman A; Kremer WW; Bleeker MCG; Jenkins D; van de Sandt M; Heideman DAM; Steenbergen R; Snijders PJF; Quint WGV; Berkhof J; Meijer CJLM
    J Clin Pathol; 2018 Nov; 71(11):981-988. PubMed ID: 30012698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
    Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
    Li Y; Liu J; Gong L; Sun X; Long W
    Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.
    Griffin H; Soneji Y; Van Baars R; Arora R; Jenkins D; van de Sandt M; Wu Z; Quint W; Jach R; Okon K; Huras H; Singer A; Doorbar J
    Mod Pathol; 2015 Jul; 28(7):977-93. PubMed ID: 25953390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1.
    Zhong P; Li J; Gu Y; Liu Y; Wang A; Sun Y; Lu L
    Int J Clin Exp Pathol; 2015; 8(3):2979-86. PubMed ID: 26045807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
    Vink FJ; Meijer CJLM; Hesselink AT; Floore AN; Lissenberg-Witte BI; Bonde JH; Pedersen H; Cuschieri K; Bhatia R; Poljak M; Oštrbenk Valenčak A; Hillemanns P; Quint WGV; Del Pino M; Kenter GG; Steenbergen RDM; Heideman DAM; Bleeker MCG
    Clin Infect Dis; 2023 Feb; 76(3):e827-e834. PubMed ID: 35686306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical values of HPV L1 and p16INK4a protein in uterine cervical lesions].
    Song Y; Li Q; Li L; Chen W; Shen GH; Qiao YL; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):352-5. PubMed ID: 22883455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV L1 and P16 Expression in CIN1 to Predict Future CIN2.
    Liu C; Du H; Wang C; Belinson JL; Yang B; Zhang W; Tang J; Wu R
    Int J Gynecol Pathol; 2017 May; 36(3):281-288. PubMed ID: 28277314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.
    Carozzi F; Cecchini S; Confortini M; Becattini V; Cariaggi MP; Pontenani G; Sani C; Ciatto S
    Cancer; 2006 Apr; 108(2):119-23. PubMed ID: 16411180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus.
    Eleutério J; Giraldo PC; Gonçalves AK; Cavalcante DI; de Almeida Ferreira FV; Mesquita SM; Morais SS
    Acta Obstet Gynecol Scand; 2007; 86(1):94-8. PubMed ID: 17230296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.